Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.
Garypidou
Vasilia
V
Verrou
Evgenia
E
Vakalopoulou
Sofia
S
Perifanis
Vasilios
V
Tziomalos
Konstantinos
K
Venizelos
Ioannis
I
D000368:Aged; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin